Introduction
Does benzene cause multiple myeloma? In 1990, Goldstein (1) argued that it is reasonable, although not scientifically proven, to causally relate benzene exposure to multiple myeloma. The evidence remains less than definitive in that the level of proof of such a relationship does not meet that required for a statement of scientific certainty, although it is rapidly approaching this point.
The evidence then consisted of a few case series of benzene-exposed multiple myeloma cases and of cases in a few epidemiological studies of benzene-exposed workers. The first two case reports of multiple myeloma in benzene-exposed workers were from Torres et al. (2) in 1970. A subsequent report of four cases came from Aksoy et al. (3) in 1984. The first report of multiple myeloma cases in an epidemiological study of benzene-exposed workers was from Decoufle et al. (4) in 1983, and the first (and only) report of a statistically significant excess of multiple myeloma in a cohort of benzene-exposed workers was from Rinsky et al. (5) in 1987. Although the four multiple myeloma cases reported by Rinsky et al. in 1987 represented a statistically significant excess in his analysis of Ohio Pliofilm worker mortality through 1981, the subsequent analysis of mortality through 1987 (6) found that the mortality risk for multiple myeloma no longer showed a statistically significant elevation. These earlier studies were sufficient to raise the hypothesis that benzene exposure was a risk factor for multiple myeloma but not to test that hypothesis. The current report contains an analysis of the published population-based and hospital-based case-control studies to test that hypothesis.
Multiple myeloma is one of the neoplasms of the lymphatic and hematopoietic system. It is a malignant tumor of the plasma cell that is derived from B lymphocytes and located primarily in the bone marrow. It is differentiated from Hodgkin's and non-Hodgkin's lymphomas and from the leukemias. Previous analysis has demonstrated that acute myelogenous leukemia (AML) and its variants are consistently associated with benzene exposure but that the other leukemias are not (7) . This report examines whether multiple myeloma and benzene exposure are consistently associated.
Methods and Materials Study Design and Base
The epidemiological literature examining whether a specific risk factor (exposure) and a specific disease (outcome) are associated consists of cohort studies and case-control studies. In the cohort studies, persons with the exposure and persons without the exposure are followed forward in time to observe the comparative frequencies of specific diseases (or causes of death) among them. In the case-control studies, the histories of persons with the disease and of persons without the disease are examined for the comparative frequencies of prior exposures to various possible risk factors. Case-control studies can be carried out within a geographically specified population, a hospital or clinic or a group of hospitals or clinics, or an exposure cohort.
This analysis is based on the published papers of population-based or hospital-based case-control studies of multiple myeloma that provide risk ratios examining the frequencies of reported exposures to benzene or to surrogates of benzene exposure. Disease Outcome Multiple myeloma is a clearly defined malignant neoplasm of the plasma cell characterized by at least two of the following three diagnostic criteria: plasma cell infiltration in bone marrow smears or secretions, definite osteolytic lesions in skeletal X-rays, and monoclonal paraproteins in the serum or urine. Most population-based and hospital-based case-control studies involve multiple myeloma cases in which this diagnosis has been clinically confirmed by pathological and/or clinical review. This is in contrast to cohort studies whose criteria for diagnosis are usually limited to information from the death certificate. gasoline (one), petroleum products (one), and oil products (one) * petroleum products employment: auto mechanic (one), refinery worker (two), and gasoline station/garage worker (two) * petroleum combustion products: engine exhausts (five), diesel exhausts (one), and gasoline exhausts (one). Within these 13 studies, 20 odds ratios were placed into the above groupings.
Results
Thirteen studies were found that met the criteria for this analysis. Odds ratios or risk ratios for exposure to benzene or to surrogates for benzene exposure were identified along with their 95% confidence limits where possible ( Figure 1) . Two of the studies (11, 17) cited benzene as an analyzed exposure. Three of the studies (10, 14, 19) (17) , in a hospital-based study from Baltimore, Maryland, reported an odds ratio of 1.2 for benzene exposure with a 95% confidence interval from 0.4 to 3.6. Heineman et al. (11) , in a population-based study of Danish males, reported an odds ratio of 0.8 for probable benzene exposure with a 95% confidence interval of 0.6 to 1.1. Both odds ratios approximated 1.
Heineman et al. (11) also reported an odds ratio for possible benzene exposure of 1.3 with a 95 % confidence interval of 1.0 to 1.6. This borderline significant association of 1.3 was found when the uncertain benzene exposure category of "possible exposure" was used, while no association was found (0.8) when the more certain benzene exposure category of "probable exposure" was used. Heineman et al. (11) further reported a trend toward a lower risk of multiple myeloma with a greater duration of exposure to benzene. These observations are contrary to the expectations for a causal relationship between multiple myeloma and benzene exposure.
Three case-control studies reported odds ratios specifically for exposure categories that included persons specified as having benzene exposure (e.g., solvents or aromatic hydrocarbons). These groups would also include persons whose exposures had been specified as being from a specific substance other than benzene. Pottern et al. (10) reported an odds ratio among Danish female cases of 0.8 for exposure to any organic solvents including benzene; Morris et al. (19) reported an odds ratio of 0.6 (95% CI 0.3-1.0) for exposure to aromatic hydrocarbons, and Flodin et al. (14) reported a risk ratio of 1.0 (95% CI 0.6-1.8) for exposure to solvent, a grouping that included benzene exposure (personal communication). The above studies consistently show no association of multiple myeloma in groups with or without benzene-exposed workers (Figure 2 ). Two studies examined for a linear trend in the risk by duration of exposure. Cuzick et al. (12) showed a trend toward a lower risk of multiple myeloma with a greater duration of exposure to solvent/benzene, and La Vecchia et al. (13) showed a risk for solvent/benzene that was significantly higher only after age and gender adjustment of the data.
In the absence of analyses specifically for benzene exposure, analyses for surrogates of benzene exposure have been reviewed. Because major occupational exposures to benzene come from petroleum products, either directly or from their combustion products, analyses relating to petroleum products, petroleum combustion products, or occupations with petroleum exposure were assessed as surrogates for benzene exposure. Odds ratios for exposures to petroleum products [with one exceptionLinet et al. (17)] were not significantly increased (i.e., 95 % lower confidence limit > 1.0). Odds ratios for petroleum-related employment rarely exceeded 1.0, and none significantly. In contrast, odds ratios for exposures to petroleum combustion product tended to be somewhat elevated, with two studies showing statistically significant elevations (14, 21) .
Most studies that reported odds ratios for multiple myelomas and benzene exposure also reported odds ratios for multiple myelomas and benzene surrogate exposures. Linet et al. (17) reported a nonsignificant odds ratio for benzene exposure of 1.2 and a statistically significant odds ratio of 3.7 for petroleum exposure. Heineman et al. (11) reported a nonsignificant odds ratio for probable benzene exposure of 0.8 and nonsignificant odds ratios for oil products and for gasoline exposures of 1.4. Flodin et al. (14) reported a rate ratio of 1.0 for the category that included benzene exposure (solvents) and a significantly elevated rate ratio of 2.3 for the benzene surrogate exposure category of engine exhaust. Finally, Pottern et al. (10) reported a nonsignificant odds ratio for probable benzene exposure of 0.8 and a nonsignificant odds ratio for engine exhaust of 1.6. If benzene exposure were the etiological agent expressed by the odds ratio for the benzene surrogates, the odds ratio for the benzene exposure would be expected to exceed the odds ratio for the surrogate benzene exposure. Since the opposite is observed (Figure 3) , it is unlikely that benzene exposure is the explanatory factor.
The above analyses have demonstrated that the population-based and hospital-based case-control studies for multiple myeloma generally do not show a significant association for benzene exposures, mixed benzene exposures, petroleum products exposures, or petroleum-related employments. These results do not lead to a finding that benzene is a cause of multiple myeloma.
Exposures to petroleum combustion products, however, tend to have somewhat elevated odds ratios, some of which show statistically significant elevations. Since products of combustion consist of a wide range of carcinogenic and noncarcinogenic constituents, no particular constituent can be positively distinguished. However, as in the studies by Heineman et al. (11) and Pottern et al. (10) , the odds ratio for probable benzene exposure was less than 1.0 and for probable engine exhaust or exhaust gases was greater than 1.0; therefore benzene exposure, is unlikely to be the explanatory factor.
The methodologies for exposure ascertainment have varied among the studies. Most studies begin with a work history retrospectively obtained by interview (13), telephone (17) , or mail (14) . Some studies began with concurrently developed work histories maintained by government agencies (11, 14) . Authors have used external evaluators to categorize occupational information based on the expertise of a toxicologist (14) or of industrial hygienists (11, 14) or have relied on the assessment of the interviewee (17) . The area of validation of exposure ascertainments is a developing field.
Cigarettes and automobiles are the major sources of human exposure to benzene (22) . Three of the case-control studies (14, 17, 18) (9, 12, 13, 15, 16, 18) reported positive associations for farming or agriculture. Others, however (19) , reported a positive association for pesticide; and Linet et al. (17) found no association with agriculture. Further, Linet et al. (17) reported a significant association with asbestos exposure; Morris et al. (19) Thus, causal agents for multiple myeloma have not been found. Nonetheless, in spite of the reports from the 1970s and 1980s that suggested an association between multiple myeloma and benzene exposure, review of the population-based and hospital-based case-control studies in the mid-1990s reveal that benzene exposure is unlikely to be a causal agent for multiple myeloma. The odds ratios for those studies that have examined benzene exposure are approximately 1.0. Exposures to chemicals in categories containing benzene, exposures to petroleum products, and employment in petroleumrelated occupations do not appear to be risk factors for multiple myeloma. Products of combustion described as "engine exhaust" have a suggested association, while products of combustion described as "cigarette smoking" do not, cigarette smoking often being considered a surrogate for benzene exposure. Much of the literature on risk factors for multiple myeloma is ambivalent. The current published case-control literature on benzene exposure is not ambivalent and does not indicate that benzene exposure is a risk factor for multiple myeloma.
